Corrigendum to: Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology: Cardiopulmonary exercise testing and prognosis in HF (European Journal of Heart Failure, (2018), 20, 1, (3-15), 10.1002/ejhf.979);Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology

European Journal of Heart Failure

Volumn 20, Issue 1, 2018, Pages 3-15

  Corrà, Ugo ^a   Agostoni, Pier Giuseppe ^b   Anker, Stefan D ^c,p,q   Coats, Andrew J S ^d   Crespo Leiro, Maria G ^e   de Boer, Rudolph A ^f   Hairola, Veli Pekka ^g   Hill, Loreena ^h   Lainscak, Mitja ⁱ   Lund, Lars H ^j   Metra, Marco ^k   Ponikowski, Piotr ^l   Riley, Jillian ^m   Seferović, Petar M ⁿ   Piepoli, Massimo F ^o  

^a IRCCS   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e HOSPITAL JUAN CANALEJO   (Spain)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g UNIVERSITY OF HELSINKI   (Finland)

^h QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

ⁱ UNIVERSITY OF LJUBLJANA   (Slovenia)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k UNIVERSITY OF BRESCIA   (Italy)

^l WROCLAW MEDICAL UNIVERSITY   (Poland)

^m NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

ⁿ UNIVERSITY OF BELGRADE   (Serbia)

^o GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^p UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^q DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

more..

Author keywords

Exercise testing; Heart failure; Prognosis

Indexed keywords

ADULT; AEROBIC EXERCISE; ANAEROBIC THRESHOLD; ARTICLE; ATRIAL FIBRILLATION; CARDIOPULMONARY EXERCISE TEST; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; EXERCISE; EXERCISE PHYSIOLOGY; FEMALE; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; LUNG GAS EXCHANGE; LUNG MINUTE VOLUME; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORBIDITY; OXYGEN CONSUMPTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPRODUCIBILITY; RISK ASSESSMENT; SEX DIFFERENCE; CARDIOLOGY; EUROPE; EXERCISE TEST; EXERCISE TOLERANCE; HEART STROKE VOLUME; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; STANDARDS;

CARDIOLOGY; EUROPE; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; STROKE VOLUME;

EID: 85041481316     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.1186     Document Type: Erratum

References (122)

1. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmund LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778–786.
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388–2442.
3. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803–869.
4. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Veli-Pekka Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016;18:891–975.
5. Mehra MR, Canter CE, Hannan MM, Semigran MJ, MD, Uber PA, Baran DA, MD, Danziger-Isakov L, Kirklin JK, Kirk R, Kushwaha SS, Lund LH, Potena L, Ross HI, Taylor DO, Verschuuren EA, Zuckermann A; International Society for Heart Lung Transplantation (ISHLT) Infectious Diseases Council; International Society for Heart Lung Transplantation (ISHLT) Pediatric Transplantation Council; International Society for Heart Lung Transplantation (ISHLT) Heart Failure and Transplantation Council. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant 2016;35:1–23.
6. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/US United Network of Organ Sharing data, 1990 to 2005. J Am Coll Cardiol 2007;50:1282–1290.
7. Corrà U, Piepoli MF, Adamopoulos S, Agostoni P, Coats AJ, Conraads V, Lambrinou E, Pieske B, Piotrowicz E, Schmid JP, Seferović PM, Anker SD, Filippatos G, Ponikowski PP. Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the ESC. Eur J Heart Fail 2014;16:929–941.
8. Alba AC, MD, Adamson AA, Macisacc J, Lalonde SD, Chan WS, Deldago DH, MD, MSc, Ross HJ. The added value of exercise variables in heart failure prognosis. J Card Fail 2016;22:492–497.
9. Cowburn PJ, Cleland JG, Coats AJ, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998;19:696–710.
10. Drinkwater BL. Women and exercise: physiological aspects. Exerc Sport Sci Rev 1984;12:21–51.
11. Harms CA. Does gender affect pulmonary function and exercise capacity? Respir Physiol Neurobiol 2006;151:124–131.
12. Daida H, Allison TG, Johnson BD, Squires RW, Gau GT. Comparison of peak exercise oxygen uptake in men versus women in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997;80:85–88.
13. Pina IL, Kokkinos P, Kao A, Bittner V, Saval M. Clare B, Goldberg L, Johnson M, Swank A, Ventura H, Moe G, Fitz-Gerald M, Ellis SJ, Vest M, Cooper L, Whellan D; HF-ACTION Investigators. Baseline differences in the HF-ACTION trial by sex. Am Heart J 2009;158(4 Suppl):S16–S23.
14. Richards DR, Mehra MR, MD, Ventura HO, Lavie CJ, Smart FW, Stapleton DD, MD, Milani RV. Usefulness of peak oxygen consumption in predicting outcome of heart failure in women versus men. Am J Cardiol 1997;80:1236-1238.
15. Elmariah S, Goldberg LR, Allen MT, Kao A. Effects of gender on peak oxygen consumption and the timing of cardiac transplantation. J Am Coll Cardiol 2006;47:2237–2242.
16. Guazzi M, Arena R, Myers J. Comparison of the prognostic value of cardiopulmonary exercise testing between male and female patients with heart failure. Int J Cardiol 2006;113:395–400.
17. Green P, Lund LH, Mancini D. Comparison of peak exercise oxygen consumption and the Heart Failure Survival Score for predicting prognosis in women versus men. Am J Cardiol 2007;99:399–403.
18. Hsich E, Chadalavada S, Krishnaswamy G, Starling RC, Pothier CE, Blackstone EH, Lauer MS. Long-term prognostic value of peak oxygen consumption in women versus men with heart failure and severely impaired left ventricular systolic function. Am J Cardiol 2007;100:291–295.
19. Corrà U, Mezzani A, Giordano A, Pistono M, Gnemmi M, Caruso R, Giannuzzi P. Peak oxygen consumption and prognosis in heart failure: 14 mL/kg/min is not a “gender-neutral” reference. Int J Cardiol 2013;167:157–161.
20. Corrà U, Agostoni P, Giordano A, Cattadori G, Battaia E, La Gioia R, Scardovi AB, Emdin M, Metra M, Sinagra G, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Magrì D, Fiorentini C, Cicoira MA, Salvioni E, Giovannardi M, Veglia F, Mezzani A, Scrutinio D, Di Lenarda A, Ricci R, Apostolo A, Iorio AM, Paolillo S, Palermo P, Contini M, Vassanelli C, Passino C, Giannuzzi P, Piepoli MF; MECKI Score Research Group. Sex profile and risk assessment with cardiopulmonary exercise testing in heart failure: propensity score matching for sex selection bias. Can J Cardiol 2016;32:754–759.
21. Komajda M, Hanon O, Hochadel M, Lopez-Sendon JL, Follath F, Ponikowski P, Harjola VP, Drexler H, Dickstein K, Tavazzi L, Nieminen M. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Heart J 2009;30:478–486.
22. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation 2003;107:346–354.
23. Scardovi AB, Coletta C, De Maria R, Perna S, Aspromonte N, Feola M, Rosso G, Greggi M, Ceci V. The cardiopulmonary exercise test is safe and reliable in elderly patients with chronic heart failure. J Cardiovasc Med 2007;8:608–612.
24. Forman DE, Clare R, Kitzman DW, Ellis SJ, Fleg JL, Chiara T, Fletcher G, Kraus WE; HF-ACTION Investigators. Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study. Am Heart J 2009;158(4 Suppl):S6–S15.
25. Davies LC, Francis DP, Piepoli M, Scott AC, Ponikowski P, Coats AJ. Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification. Heart 2000;83:147–151.
26. Cicoira M, Davos CH, Florea V, Shamim W, Doehner W, Coats AJ, Anker SD. Chronic heart failure in the very elderly: clinical status, survival, and prognostic factors in 188 patients more than 70 years old. Am Heart J 2001;142:174–180.
27. Mejhert M, Linder-Klingsell E, Edner M, Kahan T, Persson H. Ventilatory variables are strong prognostic markers in elderly patients with heart failure. Heart 2002;88:239–243.
28. Brubaker PH, Marburger CT, Morgan TM, Fray B, Kitzman DW. Exercise responses of elderly patients with diastolic versus systolic heart failure. Med Sci Sports Exerc 2003;35:1477–1485.
29. 2 slope in older heart failure patients with normal versus reduced ejection fraction compared with age-matched healthy controls. J Card Fail 2007;13:259–262.
30. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002;288:2144–2150.
31. Scardovi AB, De Maria R, Celestini A, Perna S, Coletta C, Feola M, Aspromonte N, Rosso GL, Carunchio A, Ferraironi A, Pimpinella A, Ricci B. Additive prognostic value of cardiopulmonary exercise testing in elderly patients with heart failure. Clin Sci (Lond) 2009;116:415–422.
32. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Kitzman DW, Peberdy MA, Bensimhon D, Chase P, Guazzi M. Cardiopulmonary exercise testing is equally prognostic in young, middle-aged and older individuals diagnosed with heart failure. Int J Cardiol 2011;151:278–283.
33. Carubelli V, Metra M, Corrà U, Magrì D, Passino C, Lombardi C, Scrutinio D, Correale M, Cattadori G, Piepoli MF, Salvioni E, Giovannardi M, Raimondo R, Cicoira M, Belardinelli R, Guazzi M, Limongelli G, Clemenza F, Parati G, Scardovi AB, Di Lenarda A, Maurizio Bussotti M, La Gioia R, Agostoni PG; MECKI Score Research Group. Exercise performance is a prognostic indicator in elderly patients with chronic heart failure—application of Metabolic Exercise Cardiac Kidney Indexes score. Circ J 2015;79:2608–2615.
34. 2 in elderly patients with heart failure. Int J Cardiol 2008;125:166–171.
35. Lavie CJ, McAuley PA, Church TS, MD, Milani RV, MD, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 2014;63:1345–1354.
36. Lavie CJ, Cahalin LP, Chase P, Myers J, Bensimhon D, Peberdy MA, Ashley E, West E, Forman DE, Guazzi M, Arena R. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 2013;88:251–258.
37. Piepoli MF, Corrà U, Veglia F, Bonomi A, Salvioni E, Cattadori G, Metra M, Sinagra G, Limongelli G, Raimondo R, Re F, Magrì D, Belardinelli R, Parati G, Minà C, Scardovi AB, Guazzi M, Cicoira M, Scrutinio D, Di Lenarda A, Bussotti M, Frigerio M, Correale M, Paolillo S, Passino C, Agostoni P; MECKI Score Research Group. Exercise intolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group. Eur J Heart Fail 2016;18:545–553.
38. Chase P, Arena R, Myers J, Abella J, Peberdy MA, Guazzi M, Bensimhon D. Relation of the prognostic value of ventilatory efficiency to body mass index in patients with heart failure. Am J Cardiol 2008;101:348–352.
39. Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV. The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol 2000;36:2126–2131.
40. Davos CH, Doehner W, Piepoli M, Coats AJ, Anker SD. Lean tissue-adjusted peak oxygen consumption in chronic heart failure patients. Hellenic J Cardiol 2003;44:243–250.
41. Ingle L, Sloan R, Carroll S, Goode K, Cleland JG, Clark AL. Influence of body mass on risk prediction during cardiopulmonary exercise testing in patients with chronic heart failure. Exp Clin Cardiol 2012;17:179–182.
42. Agostoni P, Emdin M, Corrà U, Veglia F, Magri D, Tedesco CC, Berton E, Passino C, Bertella E, Re F, Mezzani A, Belardinelli R, Colombo C, La Gioia R, Vicenzi M, Giannoni A, Scrutinio D, Giannuzzi P, Tondo C, Di Lenarda A, Sinagra G, Piepoli MF, Guazzi M. Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. Eur Heart J 2008;29:2367–2372.
43. Paolillo S, Agostoni PG, Masarone D, Corrà U, Passino C, Scrutinio D, Correale M, Cattadori G, Metra M, Girola D, Piepoli MF, Salvioni E, Giovannardi M, Iorio AM, Emdin M, Raimondo R, Re F, Cicoira M, Belardinelli R, Guazzi M, Clemenza F, Parati G, Scardovi AB, Di Lenarda A, La Gioia R, Frigerio M, Lombardi C, Gargiulo P, Sinagra G, Pacileo G, Perrone-Filardi, Limongelli G; Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) Score Research Group. Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI Score Research Group. Eur J Intern Med 2015;26:515–520.
44. Magrì D, Agostoni P, Corrà U, Passino C, Scrutinio D, Perrone-Filardi P, Correale M, Cattadori G, Metra M, Girola D, Piepoli MF, Iorio AM, Emdin M, Raimondo R, Re F, Cicoira MA, Belardinelli R, Guazzi M, Limongelli G, Clemenza F, Parati G, Frigerio M, Casenghi M, Scardovi AB, Ferraironi A, Di Lenarda A, Bussotti M, Apostolo A, Paolillo S, La Gioia R, Gargiulo P, Palermo P, Minà C, Farina S, Battaia E, Maruotti A, Pacileo G, Contini M, Oliva F, Ricci R, Sinagra G; Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) Score Research Group. Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation. Eur J Prev Cardiol 2015;22:1046–1055.
45. Corrà U, Pistono M, Mezzani A, Gnemmi M, Tarro Genta F, Caruso R, Giannuzzi P. Cardiovascular prevention and rehabilitation for patients with ventricular assist device: from exercise therapy to long-term therapy. Part I: Exercise therapy. Monaldi Arch Chest Dis 2011;76:27–32.
46. Jung MH, Gustafsson F. Exercise in heart failure patients supported with a left ventricular assist device. J Heart Lung Transplant 2015;34:489–496.
47. Stevenson LW, Shekar P. Ventricular assist devices for durable support. Circulation 2005;112:e111–e115.
48. Piepoli MF, Binno S, Corrà U, Seferovic P, Conraads V, Jaarsma T, Schmid JP, Filippatos G, Ponikowski PP; Committee on Exercise Physiology & Training of the Heart Failure Association of the ESC. ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients. Eur J Heart Fail 2015;17:631–638.
49. Van Deursen VM, Urso R, Laroche C, Damman K, Dahlström U, Tavazzi L, Maggioni AP, Voors AA. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 2014;16:103–111.
50. Triposkiadis F, Giamouzis G, Parissis J, Starling RC, Boudoulas H, Skoularigis J, Butler J, Filippatos G. Reframing the association and significance of co-morbidities in heart failure. Eur J Heart Fail 2016;18:744–758.
51. Arena R, Sietsma KE. Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation 2011;123:668–680.
52. Guazzi M, Myers J, Vicenzi M, Bensimhon D, Chase P, Pinkstaff S, Arena R. Cardiopulmonary exercise testing characteristics in heart failure patients with and without concomitant chronic obstructive pulmonary disease. Am Heart J 2010;160:900–905.
53. Mentz RJ, Schulte PJ, L. Fleg JL, Fiuzat M, Pharm D, Kraus WE, Piña IL, Keteytian SJ, Kitzman DW, Whellan DJ, Ellis SJ, O'Connor CM. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION). Am Heart J 2013;165:193–199.
54. Barron A, Francis DP, Mayet J, Ewert R, Obst A, Mason M, Elkin S, Hughes AD, Wensel R. Oxygen uptake efficiency slope and breathing reserve, not anaerobic threshold, discriminate between patients with cardiovascular disease over chronic obstructive pulmonary disease. JACC Heart Fail 2016;4:252–261.
55. Apostolo A, Laveneziana PA, Palange P, Agalbato C, Molle R, Popovic D, Bussotti M, Internullo M, Sciomer S, Bonini M, Alencar MC, Godinas L, Arbex F, Garcia G, Neder A, Agostoni P. Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure. Int J Cardiol 2015;189:134–140.
56. Gargiulo P, Apostolo A, Perrone-Filardi P, Sciomer S, Palange P, Agostoni PG. A non invasive estimate of dead space ventilation from exercise measurements. PLoS One 2014;9:e87395.
57. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003;167:544–549.
58. Hiraga T, Maekura R, Okuda Y, Okamoto T, Hirotani A, Kitada S, Yoshimura K, Yokota S, Ito M, Ogura T. Prognostic predictors for survival in patients with COPD using cardiopulmonary exercise testing. Clin Physiol Funct Imaging 2003;23:324–331.
59. Lacasse M, Maltais F, Poirier P, Lacasse Y, Marquis K, Jobin J, LeBlanc P. Post-exercise heart rate recovery and mortality in chronic obstructive pulmonary disease. Respir Med 2005;99:877–886.
60. Kawuta SM, O'Sheac MK, Bartelsd MN, Wilta JS, Sonettc JR, Arcasoya SM. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 2005;99:1431–1439.
61. Groepenhoff H, Vonk-Noordegraaf A, Boonstra A, Spreeuwenberg MD, Postmus PE, Bogaard HJ. Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc 2008;40:1725–1732.
62. Ferrazza AM, Martolini D, Valli G, Palange P. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration 2009;77:3–17.
63. Arena R. Exercise testing and training in chronic lung disease and pulmonary arterial hypertension. Prog Cardiovasc Dis 2011;53:454–463.
64. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J; EACPR; AHA. EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 2012;33:2917–2927.
65. Guazzi, M, Arena R, Halle M, Piepoli MF, Myers J, Lavie CJ. 2016 Focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 2016;133:e694–e711.
66. Fang ZY, Sharman J, Prins JB, Marwick TH. Determinants of exercise capacity in patients with type 2 diabetes. Diabetes Care 2005;28:1643–1648.
67. Estacio RO, Regensteiner JG, Wolfel EE, Jeffers B, Dickenson M, Schrier RW. The association between diabetic complications and exercise capacity in NIDDM patients. Diabetes Care 1998;21:291–295.
68. Guazzi M, Brambilla R, Pontone G, Agostoni PG, MD, Guazzi MD. Effect of non-insulin-dependent diabetes mellitus on pulmonary function and exercise tolerance in chronic congestive heart failure. Am J Cardiol 2002;89:191–197.
69. Guazzi M, Tumminello G, Matturri M, Guazzi MD. Insulin ameliorates exercise ventilatory efficiency and oxygen uptake in patients with heart failure-type 2 diabetes comorbidity. J Am Coll Cardiol 2003;42:1044–1050.
70. Notarius CF, Millar PJ, Murai H, Morris BL, Floras JS. Inverse relationship between muscle sympathetic activity during exercise and peak oxygen uptake in subjects with and without heart failure. J Am Coll Cardiol 2014;63:605–606.
71. Van Laethem C, Bartunek J, Goethals M, Verstreken S, Walravens M, De Proft M, Keppens C, Calders P, Vanderheyden M. Chronic kidney disease is associated with decreased exercise capacity and impaired ventilatory efficiency in heart transplantation patients. J Heart Lung Transplant 2009;28:446–452.
72. Ting SM, Hamborg T, McGregor G, Oxborough D, Lim K, Koganti S, Aldridge N, Imray C, Bland R, Fletcher S, Krishnan NS, Higgins RM, Townend J, Banerjee P, Zehnder D. Reduced cardiovascular reserve in chronic kidney failure: a matched cohort study. Am J Kidney Dis 2015;66:274–284.
73. Smart NA, William AD, Levinger I, Selig S, Howdene E, Coombese JS, Fassette RG. Exercise & Sports Science Australia (ESSA) position statement on exercise and chronic kidney disease. J Sci Med Sport 2013;16:406–411.
74. Scrutinio D, Agostoni PG, Gesualdo L, Corrà U, Mezzani A, Piepoli M, Di Lenarda A, Iorio A, Passino C, Magrì D, Masarone D, Battaia E, Girola D, Re F, Cattadori G, Parati G, Sinagra G, Villani GQ, Limongelli G, Pacileo G, Guazzi M, Metra M, Frigerio M, Cicoira M, Minà C, Malfatto G, Caravita S, Bussotti M, Salvioni E, Veglia F, Correale M, Scardovi AB, Emdin M, Giannuzzi P, Gargiulo P, Giovannardi M, Perrone-Filardi P, Raimondo R, Ricci R, Paolillo S, Farina S, Belardinelli R, Passantino A, La Gioia R; Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) Score Research Group. Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction. Circ J 2015;79:583–591.
75. Kalra PR, Bolger AP, Francis DP, Genth-Zotz S, Sharma R, Ponikowski PP, Poole-Wilson PA, Coats AJ, Anker SD. Effect of anemia on exercise tolerance in chronic heart failure in men. Am J Cardiol 2003;91:888–891.
76. Agostoni P, Salvioni E, Debenedetti C, Vignati C, Cattadori G, Contini M, Magrì D, Palermo P, Gondoni E, Brusoni D, Fiorentini C, Apostolo A. Relationship of resting hemoglobin concentration to peak oxygen uptake in heart failure patients. Am J Hematol 2010;85:414–417.
77. Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, Cleland JG, van Veldhuisen DJ, Hillege HL. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 2007;13:599–608.
78. Ponikowski P, Anker SD, Szachniewicz J, Okonko D, Ledwidge M, Zymlinski R, Ryan E, Wasserman SM, Baker N, Rosser D, Rosen SD, Poole-Wilson PA, Banasiak W, Coats AJ, McDonald K. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2007;49:753–762.
79. Wright SE, Pearce B, Snowden CP, Anderson H, Wallis JP Cardiopulmonary exercise testing before and after blood transfusion: a prospective clinical study. Br J Anaesth 2014;113:91–96.
80. 2 slope in anemic patients. Int J Clin Cardiol 2015,2:2–5.
81. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P; FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436–2448.
82. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Von Heahling S, Doehner W, Banasiak W, Polonski L, Filippatos G, Anker SD, Ponikowski P. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail 2011;17:899–906.
83. Cattadori G, Agostoni P, Corrà U, Sinagra G, Veglia F, Salvioni E, Bonomi A, La Gioia R, Scardovi AB, Ferraironi A, Emdin M, Metra M, Di Lenarda A, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Caravita S, Magrì D, Lombardi C, Frigerio M, Oliva F, Girola D, Mezzani A, Farina S, Mapelli M, Scrutinio D, Pacileo G, Apostolo A, Iorio AM, Paolillo S, Perrone Filardi P, Gargiulo P, Bussotti M, Marchese G, Correale M, Badagliacca R, Sciomer S, Palermo P, Contini M, Giannuzzi P, Battaia E, Cicoira M, Clemenza M, Minà, Binno S, Passino C, Piepoli MF; MECKI Score Research Group. Heart failure and anemia: effects on prognostic variables. Eur J Intern Med 2017;37:56–63.
84. Passino C, Poletti R, Bramanti F, Prontera C, Clerico A, Emdin M. Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure. Eur J Heart Fail 2006;8:46–53.
85. Passino C, Pingitore A, Landi P, Fontana M, Zyw L, Clerico A, Emdin M, Iervasi G. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure. J Card Fail 2009;15:35–40.
86. Fontana M, Passino C, Poletti R, Zyw L, Prontera C, Scarlattini M, Clerico A, Emdin M, Iervasi G. Low triiodothyronine and exercise capacity in heart failure. Int J Cardiol 2012;154:153–157.
87. Jones LW, Eves ND, Haykowsky M, Freedland SJ, Mackey JR. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol 2009;10:598–605.
88. Cramer L, Hildebrandt B, Kung T, Wichmann K, Springer J, Doehner W, Sandek A, Valentova M, Stojakovic T, Scharnagl H, Riess H, Anker SD, von Haehling S. Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer. J Am Coll Cardiol 2014;64:1310–1319.
89. Jones LW, Courneya KS, Mackey JR, Muss HB, Pituskin EN, Scott JM, Hornsby WE, Coan AD, Herndon JE 2nd, Douglas PS, Haykowsky M. Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol 2012;30:2530–2537.
90. Lipshultz SE, Landy DC, Lopez-Mitnik G, Lipsitz SR, Hinkle AS, Constine LS, French CA, Rovitelli AM, Proukou C, Adams MJ, Miller TL. Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. J Clin Oncol 2012;30:1050–1057.
91. Kelly JO, Kilbreath SL, PhD, Davis GM, Zeman B, Raymond J. Cardiorespiratory fitness and walking ability in subacute stroke patients. Arch Phys Med Rehabil 2003;84:1708–1785.
92. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160–2236.
93. Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, Forsting M, Harnof S, Klijn CJM, Krieger D, Mendelow AD, Molina C, Montaner J, Overgaard K, Petersson J, Roine RO, Schmutzhard E, Schwerdtfeger K, Stapf C, Tatlisumak T, Thomas BM, Toni D, Unterberg A, Wagner M; European Stroke Organisation. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 2014;9:840–855.
94. Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G; European Stroke Organization. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 2013;35:93–112.
95. Gordon NF, Gulanick M, Costa F, Fletcher G, Franklin BA, Roth EJ, Shephard T. Physical activity and exercise recommendations for stroke survivors: an American Heart Association scientific statement from the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council. Circulation 2004;109:2031–2041.
96. Gottlieb SS, Kop WJ, Ellis SJ, Binkley P, Howlett J, O'Connor C, Blumenthal JA, Fletcher G, Swank AM, Cooper L; HF-ACTION Investigators. Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]). Am J Cardiol 2009;103:1285–1289.
97. Kitzman DW, Groban L. Exercise intolerance. Heart Fail Clin 2008;4:99–115.
98. Maor E, Grossman Y, Balmor RG, Segel M, Fefer P, Ben-Zekry S, Buber J, DiSegni E, Guetta V, Ben-Dov I, Segev A. Exercise haemodynamics may unmask the diagnosis of diastolic dysfunction among patients with pulmonary hypertension. Eur J Heart Fail 2015;17:151–158.
99. Erdei T, Smiseth OA, Marino P, Fraser AG. A systematic review of diastolic stress tests in heart failure with preserved ejection fraction, with proposals from the EU-FP7 MEDIA study group. Eur J Heart Fail 2014;16:1345–1361.
100. Farr MJ, Lang CC, LaManca JJ, Zile MR, Francis G, Tavazzi L, Gaasch WH, St John Sutton M, Itoh H, Mancini D; MCC-135 GO1 Investigators. Cardiopulmonary exercise variables in diastolic versus systolic heart failure. Am J Cardiol 2008;102:203–206.
101. Guazzi M, Myers J, Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol 2005;46:1883–1890.
102. Guazzi M, Myers J, Peberdy MA, Bensimhon D, Chase P, Arena R. Exercise oscillatory breathing in diastolic heart failure: prevalence and prognostic insights. Eur Heart J 2008;29:2751–2759.
103. Shafiq A, Brawner CA, Aldred HA, Lewis B, Williams CT, Tita C, Schairer JR, Ehrman JK, Velez M, Selektor Y, Lanfear DE, Keteyian SJ. Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project. Am Heart J 2016;174:167–172.
104. Malhotra R, Bakken K, D'Elia E, Lewis GD. Cardiopulmonary exercise testing in heart failure. JACC Heart Fail 2016;4:607–616.
105. Skalski J, Allison TG, Miller TD. The safety of cardiopulmonary exercise testing in a population with high-risk cardiovascular diseases. Circulation 2012;126:2465–2472.
106. Keteyian SJ, Isaac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, Russell SD, Hellkamp AS, Kraus WE; HF-ACTION Investigators. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J 2009;158(4 Suppl):S72–S77.
107. Howley ET, Bassett DR Jr, Welch HG. Criteria for maximal oxygen uptake: review and commentary. Med Sci Sports Exerc 1995;27:1292–1301.
108. Bartels MN. Fatigue in cardiopulmonary disease. Phys Med Rehabil Clin N Am 2009;20:389–404.
109. 2 prognostic reliability in patients with chronic heart failure and severely reduced exercise capacity. Am Heart J 2003;145:1102–1107.
110. Pardaens K, Van Cleemput J, Vanhaecke J, Fagard RH. Peak oxygen uptake better predicts outcome than submaximal respiratory data in heart transplant candidates. Circulation 2000;101:1152–1157.
111. Ingle L, Witte KK, Cleland JG, Clark AL. The prognostic value of cardiopulmonary exercise testing with a peak respiratory exchange ratio of <1.0 in patients with chronic heart failure. Int J Cardiol 2008;127:88–92.
112. Chase PJ, Kenjale A, Cahalin LP, Arena R, Davis PG, Myers J, Guazzi M, Forman DE, Ashley E, Peberdy MA, West E, Kelly CT, Bensimhon DR. Effects of respiratory exchange ratio on the prognostic value of peak oxygen consumption and ventilatory efficiency in patients with systolic heart failure. JACC Heart Fail 2013;1:427–432.
113. Florea VG, Henein MY, Anker SD, Francis DP, Chambers JS, Ponikowski P, Coats AJ. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Eur Heart J 2000;21:146–153.
114. Corrà U, Mezzani A, Bosimini E, Giannuzzi P. Prognostic value of time-related changes of cardiopulmonary exercise testing indices in stable chronic heart failure: a pragmatic and operative scheme. Eur J Cardiovasc Prev Rehabil 2006;13:186–192.
115. 2-changes in stable CHF on chronic beta-blocker treatment. Int J Cardiol 2007;122:125–130.
116. Bensimhon DR, Leifer ES, Ellis SJ, Fleg JL, Keteyian SJ, Piña IL, Kitzman DW, McKelvie RS, Kraus WE, Forman DE, Kao AJ, Whellan DJ, O'Connor CM, Russell SD; HF-ACTION Trial Investigators. Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing). Am J Cardiol 2008;102:712–717.
117. Keteyian SJ, Brawner CA, Ehrman JK, Ivanhoe R, Boehmer JP, Abraham WT; PEERLESS-HF Trial Investigators. Reproducibility of peak oxygen uptake and other cardiopulmonary exercise parameters: implications for clinical trials and clinical practice. Chest 2010;138:950–955.
118. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Kitzman D, Peberdy MA, Bensimhon D, Chase P, Forman DE, Guazzi M. Defining the optimal prognostic window for cardiopulmonary exercise testing in patients with heart failure. Circ Heart Fail 2010;3:405–411.
119. Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JG, Cohn JN, Dickstein K, Domanski MJ, Ekman I, Filippatos GS, Gheorghiade M, Hernandez AF, Jaarsma T, Koglin J, Konstam M, Kupfer S, Maggioni AP, Mebazaa A, Metra M, Nowack C, Pieske B, Pina IL, Pocock SJ, Ponikowski P, Rosano G, Ruilope LM, Ruschitzka F, Severin T, Solomon S, Stein K, Stockbridge NL, Stough WG, Swedberg K, Tavazzi L, Voors AA, Wasserman SM, Woehrle H, Zalewski A, McMurray JJ. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail 2013;15:1082–1094.
120. Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Le Floch C, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M, Prasad K, Revkin J, Rosano GM, Somaratne R, Stough GW, Voors AA, Ruschitzka F. Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency. Eur J Heart Fail 2016;18:482–489.
121. Corrà U, Mezzani A, Bosimini E, Giannuzzi P. Cardiopulmonary exercise testing and prognosis in chronic heart failure: a prognosticating algorithm for the individual patient. Chest 2004;126:942–950.
122. Cattadori G, Agostoni P, Corrà U, Di Lenarda A, Sinagra G, Veglia F, Salvioni E, La Gioia R, Scardovi AB, Emdin M, Metra M, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Magrì D, Fiorentini C, Mezzani A, Scrutinio D, Pacileo G, Apostolo A, Iorio A, Paolillo S, Palermo P, Contini M, Giannuzzi P, Battaia E, Cicoira M, Passino C, Piepoli MF; MECKI Score Research Group. Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. Int J Cardiol 2013;168:5078–5081.